Search

Your search keyword '"Ecker, Brett L."' showing total 468 results

Search Constraints

Start Over You searched for: Author "Ecker, Brett L." Remove constraint Author: "Ecker, Brett L."
468 results on '"Ecker, Brett L."'

Search Results

2. Author Correction: Stromal changes in the aged lung induce an emergence from melanoma dormancy

Catalog

Books, media, physical & digital resources

5. Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer

9. Registry‐based randomized clinical trials in surgery: Working with ACS‐NSQIP and the AHPBA to conduct pragmatic trials

12. Stromal changes in the aged lung induce an emergence from melanoma dormancy

13. Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection Prognostication.

14. Segmental Versus Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection

15. Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations

16. Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR

17. Surgical Management of Sarcoma Metastatic to Liver

20. Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma

24. Recurrence‐free survival dynamics following adjuvant chemotherapy for resected colorectal cancer: A systematic review of randomized controlled trials

29. The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy

31. Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies

33. Association between SMAD4 Mutations and GATA6 Expression in Paired Pancreatic Ductal Adenocarcinoma Tumor Specimens: Data from Two Independent Molecularly-Characterized Cohorts

43. Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation

45. Author Correction: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis

46. Correction: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients

47. Supplementary Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

48. Supplementary Movie 1 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

49. Supplementary Movie 2 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

50. Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2